Catalyst Wire Dossier Catalyst Wire Dossier

OLOMAX

· Daewoong Pharmaceutical Co. LTD.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for OLOMAX, covering 2025-08-24 to 2025-08-24. Get the full timeline:

Most recent: Clinical Trial Update: Reduction Efficacy of OLOMAX for Blood Pressure and Low-density Lipoprotein Cholesterol in Hypertensive Patients With Dyslipidemia

See pricing